PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.07%
Negative revenue growth while EXP stands at 34.99%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.07%
Negative gross profit growth while EXP is at 77.42%. Joel Greenblatt would examine cost competitiveness or demand decline.
-6.07%
Negative EBIT growth while EXP is at 84.68%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-6.07%
Negative operating income growth while EXP is at 93.86%. Joel Greenblatt would press for urgent turnaround measures.
48.41%
Net income growth at 50-75% of EXP's 85.56%. Martin Whitman would question fundamental disadvantages in expenses or demand.
60.00%
EPS growth at 50-75% of EXP's 88.06%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
60.00%
Diluted EPS growth at 50-75% of EXP's 88.00%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-7.24%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-7.24%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.23%
10Y revenue/share CAGR under 50% of EXP's 239.77%. Michael Burry would suspect a lasting competitive disadvantage.
14.23%
5Y revenue/share CAGR under 50% of EXP's 88.22%. Michael Burry would suspect a significant competitive gap or product weakness.
14.23%
3Y revenue/share CAGR under 50% of EXP's 31.63%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.